Back to search
FDAFDA · Food and drugs·Recall number D-0130-2025

Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-475-60

Published December 18, 2024 · Recall initiated: December 12, 2024

Summary

FDA records drug Class II recall D-0130-2025, published December 18, 2024 and initiated December 12, 2024. Recalling firm: Ascend Laboratories, LLC; Status: Ongoing; Reported quantity: 10,444 bottles; Lot: Lot #: 24142192, 24142193, 24142194, Exp. Date April 30, 2026; 24142463, Exp. Date May 31, 2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit

What to do

Voluntary: Firm initiated · Letter

Get an email if DABIGATRAN ETEXILATE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DABIGATRAN ETEXILATE
Manufacturer
Ascend Laboratories, LLC
Distributor
Nationwide within the United States
UPC
0367877624600
Lot
Lot #: 24142192, 24142193, 24142194, Exp. Date April 30, 2026; 24142463, Exp. Date May 31, 2026;
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured by: Alkem Laboratories Ltd., INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054 NDC 67877-475-60 recalled?

Yes. FDA published recall D-0130-2025 on December 18, 2024. Reported hazard: CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DABIGATRAN ETEXILATE. UPC: 0367877624600.